Building Biotech: How COVID-19 changed development forever

The COVID-19 pandemic transformed vaccine development, proving that safe and effective vaccines can be developed at unprecedented speed. As the life sciences industry moves beyond crisis response, the focus has shifted to how these lessons can be embedded into future vaccine development pipelines; ranging from platform technologies and regulatory agility to manufacturing resilience, global access, and public trust.

Access the Article: Rapid Vaccine Development

This article with BioProcess International examines the critical vaccine development lessons from COVID-19 that will shape future biopharmaceutical strategies, including:

• Vaccine equity and access, including regional manufacturing and technology transfer strategies
• Public trust, vaccine hesitancy, and communication strategies critical to long-term vaccine success
• Accelerated vaccine development timelines and how parallel clinical and manufacturing models are changing industry standards
• mRNA vaccine platforms and their impact on speed, scalability, and next-generation vaccine design
• Global collaboration and data sharing challenges exposed during COVID-19, and what needs to change
• Regulatory innovation, from rolling reviews to emergency authorisations and post-market surveillance
• AI and digital tools in vaccine development, supporting predictive modelling and faster design